L. Mary Smith - 13 Jul 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief Development Officer
Signature: /s/ Francis I. Perier, Jr as Attorney-in-Fact
Issuer symbol: SWTX
Transactions as of: 13 Jul 2021
Net transactions value: -$785,777
Form type: 4
Filing time: 14 Jul 2021, 16:28:33 UTC
Next filing: 13 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Options Exercise	$23,000	+10,000	+6%	$2.30^*	177,511	13 Jul 2021	Direct	F1
transaction	SWTX	Common Stock	Sale	$808,777	-10,000	-5.6%	$80.88	167,511	13 Jul 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-9.6%	$0.000000	94,296	13 Jul 2021	Common Stock	10,000	$2.30	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $80.115 to $83.54, inclusive.
F3	Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
F4	This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.